Stocktoria
Bio Green Med Solution, Inc. BGMS
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 1996-01-01
Bio Green Med Solution, Inc. financials (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $747,000 | $43,000 | $420,000 | $0 | $0 |
| R&D expense | $848,000 | $6.7M | $19.2M | $20.3M | $15.5M |
| SG&A expense | — | $5.4M | $6.7M | $7.4M | $7.5M |
| Operating income | -$8.4M | -$12.0M | -$25.5M | -$27.7M | -$22.9M |
| Income tax | $7,000 | -$782,000 | -$3.0M | -$4.7M | -$3.8M |
| Net income | -$3.0M | -$11.2M | -$22.6M | -$21.2M | -$18.9M |
| EPS (diluted) | $-6.45 | $-502.46 | $-26.75 | $-27.24 | $-2.14 |
| Operating cash flow | -$4.8M | -$8.0M | -$16.1M | -$20.8M | -$18.5M |
| Free cash flow | — | — | -$16.1M | -$20.8M | -$18.6M |
| Cash & equivalents | $3.5M | $3.1M | $3.4M | $18.3M | $36.6M |
| Inventory | $1.4M | — | — | — | — |
| Total assets | $8.2M | $4.1M | $8.8M | $28.1M | $42.6M |
| Total liabilities | $1.3M | $6.3M | $8.2M | $7.6M | $5.3M |
| Shareholders' equity | $6.8M | -$2.2M | $607,000 | $15.9M | $37.7M |
Source: SEC EDGAR filings · CIK 0001130166 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.